Close Cardiovascular Monitoring during the Early Stages of Treatment for Patients Receiving Immune Checkpoint Inhibitors

• Main Authors: Danielle Delombaerde (Author), Christof Vulsteke (Author), Nico Van de Veire (Author), Delphine Vervloet (Author), Veronique Moerman (Author), Lynn Van Calster (Author), Anne-Marie Willems (Author), Lieselot Croes (Author), Félix Gremonprez (Author), Astrid De Meulenaere (Author), Ximena Elzo Kraemer (Author), Kristien Wouters (Author), Marc Peeters (Author), Hans Prenen (Author), Johan De Sutter (Author)
• Format: Book
• Published: MDPI AG, 2024-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<b>Background:</b> There is an unmet medical need for the early detection of immune checkpoint inhibitor (ICI)-induced cardiovascular (CV) adverse events due to a lack of adequate biomarkers. This study aimed to provide insights on the incidence of troponin elevations and echocardiograph...